# EVALUATION OF THE EFFECTIVENESS AND SAFETY OF DOSPRAY® NAZAL SPRAY IN THE SYMPTOMATIC TREATMENT OF PERSISTENT ALLERGIC RHINITIS: A POST-REGISTRATION OBSERVATION STUDY

> **NCT05896241** · — · UNKNOWN · sponsor: **LeKos LLP** · enrollment: 126 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **OTHER:** non-interventional study

## Key facts

- **NCT ID:** NCT05896241
- **Lead sponsor:** LeKos LLP
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-15
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05896241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05896241, "EVALUATION OF THE EFFECTIVENESS AND SAFETY OF DOSPRAY® NAZAL SPRAY IN THE SYMPTOMATIC TREATMENT OF PERSISTENT ALLERGIC RHINITIS: A POST-REGISTRATION OBSERVATION STUDY". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05896241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*